CPT1C Gene SPG73 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The CPT1C Gene SPG73 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with hereditary spastic paraplegia type 73. This sophisticated next-generation sequencing technology provides unparalleled accuracy in identifying genetic variations that contribute to progressive neurological conditions affecting mobility and quality of life.
What Does This Test Measure?
This advanced genetic test specifically analyzes the CPT1C gene using cutting-edge NGS technology to identify pathogenic variants responsible for SPG73, a form of hereditary spastic paraplegia. The test examines:
- Complete sequencing of the CPT1C gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of known and novel genetic variants
- Assessment of variant pathogenicity and clinical significance
Who Should Consider This Test?
This genetic test is particularly important for individuals experiencing:
- Progressive leg stiffness and muscle spasticity
- Difficulty walking or changes in gait pattern
- Muscle weakness in the lower extremities
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms beginning in childhood or adulthood
- Progressive balance and coordination issues
Clinical Benefits of Genetic Testing
Undergoing the CPT1C Gene SPG73 NGS Genetic DNA Test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out SPG73 with high precision
- Treatment Guidance: Helps neurologists develop targeted management strategies
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Early Intervention: Enables proactive management of symptoms
- Peace of Mind: Reduces diagnostic uncertainty and provides clarity
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our team of genetic specialists:
- Positive Result: Indicates the presence of a pathogenic variant in the CPT1C gene, confirming SPG73 diagnosis
- Negative Result: Suggests no detectable mutations in the CPT1C gene, though other genetic causes may need investigation
- Variant of Uncertain Significance: Identifies genetic changes whose clinical impact requires further study
- Carrier Status: Determines if you carry a single copy of a mutated gene
All results include comprehensive genetic counseling to help you understand the implications for your health and family.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | CPT1C Gene SPG73 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures accessible genetic testing services regardless of your location.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. The CPT1C Gene SPG73 NGS Genetic DNA Test provides the clarity needed to make informed healthcare decisions and develop effective management strategies for neurological symptoms.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.
Remember to bring your clinical history and be prepared for a genetic counseling session to create a detailed family pedigree chart, which helps our specialists provide the most accurate interpretation of your results.
